Your Article Summary
The adjustable continence therapy system for recurrent female stress urinary incontinence: 1-year results of the North America Clinical Study Group
International Braz J Urol, 06/25/09
Aboseif SR et al. - The Uromedica adjustable continence therapy device is an effective, simple, safe and minimally invasive treatment for recurrent female stress urinary incontinence. It can be easily adjusted percutaneously to enhance efficacy and complications are usually easily manageable. Explantation does not preclude later repeat implantation.
Related Articles
Prevalence and Severity of Undiagnosed Urinary Incontinence in Women
American Journal of Medicine, 10/27/09
Relevance Score: 71%
Urinary incontinence in obese adolescent girls
Journal of Pediatric Urology, 11/18/09
Relevance Score: 70%
Etiology and predictors of urinary incontinence and its effect on quality of life
Geriatrics and Gerontology International, 11/17/09
Relevance Score: 70%
Urinary incontinence
Internet Source, 11/04/09
Relevance Score: 70%
Urinary Incontinence Therapy Area Pipeline Report
Internet Source, 10/30/09
Relevance Score: 70%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Management of patients with advanced bladder cancer following major response to systemic chemotherapy
Expert Review of Anticancer Therapy, 12/04/09
Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer
Expert Review of Anticancer Therapy, 12/04/09
Current status of chemotherapy in risk-adapted management for metastatic testicular germ cell cancer
Cancer Science, 12/04/09
Today in Voiding Dys/Incontinence...keeping you current
Receive free subspecialty "5-minute updates" via email
A Round Table Discussion: Case Studies of Patients with Lower Urinary Tract Symptoms
Urologic Clinics of North America, 12/04/09
A longitudinal investigation of the impact of typology of urinary incontinence on quality of life during midlife
Maturitas, 12/04/09
Cizolirtine Citrate Is Safe and Effective for Treating Urinary Incontinence Secondary to Overactive Bladder: A Phase 2 Proof-of-Concept Study
European Urology, 12/03/09

See Latest Articles